vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Navitas Semiconductor Corp (NVTS). Click either name above to swap in a different company.
FENNEC PHARMACEUTICALS INC. is the larger business by last-quarter revenue ($13.8M vs $7.3M, roughly 1.9× Navitas Semiconductor Corp). FENNEC PHARMACEUTICALS INC. runs the higher net margin — -34.7% vs -436.1%, a 401.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -59.4%). Over the past eight quarters, FENNEC PHARMACEUTICALS INC.'s revenue compounded faster (-26.3% CAGR vs -43.9%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.
FENC vs NVTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $7.3M |
| Net Profit | $-4.8M | $-31.8M |
| Gross Margin | — | 38.1% |
| Operating Margin | -18.5% | -567.3% |
| Net Margin | -34.7% | -436.1% |
| Revenue YoY | 73.8% | -59.4% |
| Net Profit YoY | -141.1% | 20.2% |
| EPS (diluted) | $-0.17 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $7.3M | ||
| Q3 25 | $12.5M | $10.1M | ||
| Q2 25 | $9.7M | $14.5M | ||
| Q1 25 | $8.8M | $14.0M | ||
| Q4 24 | $7.9M | $18.0M | ||
| Q3 24 | $7.0M | $21.7M | ||
| Q2 24 | $7.3M | $20.5M | ||
| Q1 24 | $25.4M | $23.2M |
| Q4 25 | $-4.8M | $-31.8M | ||
| Q3 25 | $-638.0K | $-19.2M | ||
| Q2 25 | $-3.2M | $-49.1M | ||
| Q1 25 | $-1.2M | $-16.8M | ||
| Q4 24 | $-2.0M | $-39.9M | ||
| Q3 24 | $-5.7M | $-18.7M | ||
| Q2 24 | $-5.6M | $-22.3M | ||
| Q1 24 | $12.8M | $-3.7M |
| Q4 25 | — | 38.1% | ||
| Q3 25 | — | 37.9% | ||
| Q2 25 | — | 16.1% | ||
| Q1 25 | — | 37.9% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 39.7% | ||
| Q2 24 | — | 39.0% | ||
| Q1 24 | — | 41.1% |
| Q4 25 | -18.5% | -567.3% | ||
| Q3 25 | -1.5% | -192.0% | ||
| Q2 25 | -28.3% | -149.4% | ||
| Q1 25 | -9.2% | -180.5% | ||
| Q4 24 | -11.8% | -216.9% | ||
| Q3 24 | -74.6% | -133.6% | ||
| Q2 24 | -69.4% | -152.1% | ||
| Q1 24 | 54.2% | -136.2% |
| Q4 25 | -34.7% | -436.1% | ||
| Q3 25 | -5.1% | -190.2% | ||
| Q2 25 | -32.7% | -338.7% | ||
| Q1 25 | -13.3% | -120.1% | ||
| Q4 24 | -25.0% | -221.7% | ||
| Q3 24 | -82.2% | -86.4% | ||
| Q2 24 | -76.5% | -109.1% | ||
| Q1 24 | 50.6% | -15.9% |
| Q4 25 | $-0.17 | $-0.14 | ||
| Q3 25 | $-0.02 | $-0.09 | ||
| Q2 25 | $-0.11 | $-0.25 | ||
| Q1 25 | $-0.04 | $-0.09 | ||
| Q4 24 | $-0.02 | $-0.22 | ||
| Q3 24 | $-0.21 | $-0.10 | ||
| Q2 24 | $-0.20 | $-0.12 | ||
| Q1 24 | $0.41 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $236.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $443.7M |
| Total Assets | $70.6M | $500.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $236.9M | ||
| Q3 25 | $21.9M | $150.6M | ||
| Q2 25 | $18.7M | $161.2M | ||
| Q1 25 | $22.7M | $75.1M | ||
| Q4 24 | $26.6M | $86.7M | ||
| Q3 24 | $40.3M | $98.3M | ||
| Q2 24 | $43.1M | $111.7M | ||
| Q1 24 | $51.2M | $128.9M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $443.7M | ||
| Q3 25 | $-4.5M | $371.0M | ||
| Q2 25 | $-7.5M | $388.9M | ||
| Q1 25 | $-5.9M | $341.8M | ||
| Q4 24 | $-5.9M | $348.0M | ||
| Q3 24 | $-5.2M | $380.8M | ||
| Q2 24 | $-1.4M | $388.1M | ||
| Q1 24 | $3.0M | $397.9M |
| Q4 25 | $70.6M | $500.5M | ||
| Q3 25 | $49.3M | $430.2M | ||
| Q2 25 | $44.9M | $449.4M | ||
| Q1 25 | $46.4M | $370.8M | ||
| Q4 24 | $44.9M | $390.0M | ||
| Q3 24 | $58.9M | $419.4M | ||
| Q2 24 | $63.2M | $439.1M | ||
| Q1 24 | $69.2M | $467.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-8.1M |
| Free Cash FlowOCF − Capex | — | $-8.2M |
| FCF MarginFCF / Revenue | — | -111.8% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-44.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $-8.1M | ||
| Q3 25 | $1.5M | $-10.0M | ||
| Q2 25 | $-3.7M | $-11.2M | ||
| Q1 25 | $-4.3M | $-13.5M | ||
| Q4 24 | $-1.5M | $-10.2M | ||
| Q3 24 | $-2.2M | $-13.7M | ||
| Q2 24 | $-8.4M | $-15.1M | ||
| Q1 24 | $39.0M | $-19.8M |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-10.7M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $-13.6M | ||
| Q4 24 | — | $-10.8M | ||
| Q3 24 | — | $-14.3M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-22.7M |
| Q4 25 | — | -111.8% | ||
| Q3 25 | — | -106.1% | ||
| Q2 25 | — | -82.2% | ||
| Q1 25 | — | -96.8% | ||
| Q4 24 | — | -59.8% | ||
| Q3 24 | — | -65.9% | ||
| Q2 24 | — | -87.3% | ||
| Q1 24 | — | -97.9% |
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | — | 13.4% | ||
| Q1 24 | — | 12.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
